$FSLR

JPMorgan Adjusts Price Target on First Solar to $252 From $256

JPMorgan lowered its price target for First Solar from $256 to $252. The stock is currently trading at $172.64, down 3.45% over 5 days and 33.91% year-to-date. Barclays also recently adjusted its target for the company.

Original reporting
Published Oct 19, 2026, 9:44 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$FSLR
Bearish
high confidence
Mentioned
$FSLR
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$FSLRBearishMed
01

Why it matters

Analyst target revisions can move stock prices, especially when the change is communicated before market open.

02

Market read

A fresh analyst downgrade for First Solar may trigger short‑term price adjustments, with modest relevance to the solar sector.

03

What to watch

Potential upside from upcoming utility contracts and favorable policy incentives not reflected in the target.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

JPMorgan periodically updates price targets for covered stocks based on its valuation models and market outlook.

Company-level read

Ticker impact

$FSLRBearishHigh confidence
Context

JPMorgan lowered its price target for First Solar to $252 from $256, indicating a fresh analyst downgrade.

Expected impact

likely modest downside pressure as investors price in the lower target

Evidence & confidence

Analyst price‑target adjustments are a direct catalyst; a cut signals weaker outlook and can prompt short‑term selling.

Market effects

May weigh on the broader solar and renewable‑energy sector as analysts reassess valuation multiples.

Limited to U.S. listed solar equities; no immediate global effect.

Low; the news is company‑specific.

Counterpoint

The target cut could be an overreaction; recent project wins may support a higher valuation.

Key entities

  • First Solar

    U.S. solar panel manufacturer (ticker FSLR).

  • JPMorgan

    Equity research firm providing the price‑target adjustment.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$FSLRHigh

Why First Solar (FSLR) Stock Is Up Today

First Solar (FSLR) stock rose 1.8% after Truist Securities upgraded it to Buy with a $229 price target, citing improved pricing and demand forecasts. Shares later cooled to $180.10, up 1.3%. The upgrade follows a 32% YTD decline, with the analyst noting strong domestic demand and anti-stockpiling restrictions benefiting the company.

$FSLRHigh

Truist upgrades First Solar stock rating on stronger pricing outlook

Truist upgraded First Solar (FSLR) to Buy, raising its price target to $270 from $229. The upgrade is based on stronger pricing outlook and valuation reset, with a 17% increase in 2029 U.S. module ASP estimates. Truist forecasts strong U.S. solar installations and cites regulatory support. Other analysts have also upgraded FSLR, citing undervaluation and potential earnings drivers.

$FSLRHigh

Why is First Solar stock up over 2% today?

First Solar (FSLR) stock rose 2.4% in pre-market trading after Truist Securities upgraded it to 'Buy' and raised its price target to $270, citing favorable pricing and regulatory conditions. The stock is still below its 52-week high of $320.95. Analysts have largely positive ratings, with 26 Buys, 9 Holds, and 1 Sell. The broader market is mixed ahead of bank earnings season.